We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TOPP
3201
Toppoint Holdings
TOPP
$14.3M
| $8.59K | ﹤0.01% |
+10,617
| New | +$13K |
|
|
EHGO
3202
Eshallgo Inc
EHGO
$7.26M
| $8.58K | ﹤0.01% |
+2,486
| New | +$15.5K |
|
3203
FibroBiologics
FBLG
$3.95M
| $8.53K | ﹤0.01% |
+1,896
| New | +$13.4K |
|
3204
Milestone Scientific
MLSS
$38M
| $8.44K | ﹤0.01% |
30,923
-1,482
| -5% | -$564 |
|
|
TMDE
3205
TMD Energy Limited
TMDE
$17.2M
| $8.39K | ﹤0.01% |
19,738
-4,576
| -19% | -$3.28K |
|
3206
Modular Medical
MODD
$12.7M
| $8.36K | ﹤0.01% |
765
+371
| +94% | +$5.45K |
|
3207
Theriva Biologics
TOVX
$9.8M
| $8.3K | ﹤0.01% |
39,445
+6,546
| +20% | +$1.94K |
|
3208
Galmed Pharmaceuticals
GLMD
$4.1M
| $8.29K | ﹤0.01% |
+11,048
| New | +$12.9K |
|
|
TOUR
3209
Tuniu
TOUR
$56.9M
| $7.97K | ﹤0.01% |
1,286
-4,893
| -79% | -$38.5K |
|
3210
IGC Pharma
IGC
$27M
| $7.97K | ﹤0.01% |
28,324
-5,679
| -17% | -$2.02K |
|
|
ADVB
3211
Advanced Biomed Inc
ADVB
$18M
| $7.96K | ﹤0.01% |
1,363
-1,249
| -48% | -$10.4K |
|
|
WXM
3212
WF International Ltd
WXM
$9.05M
| $7.84K | ﹤0.01% |
+1,538
| New | +$25.3K |
|
3213
EpicQuest Education Group
EEIQ
$3.61M
| $7.79K | ﹤0.01% |
+2,238
| New | +$12.9K |
|
|
DAIC
3214
CID HoldCo Inc
DAIC
$1.22M
| $7.52K | ﹤0.01% |
670
-642
| -49% | -$33.1K |
|
|
AMOD
3215
Alpha Modus Holdings
AMOD
$17.7M
| $7.49K | ﹤0.01% |
+407
| New | +$14.3K |
|
3216
Azitra
AZTR
$2.11M
| $7.48K | ﹤0.01% |
+28,231
| New | +$12.9K |
|
3217
Virax Biolabs
VRAX
$2.3M
| $7.41K | ﹤0.01% |
+857
| New | +$10.9K |
|
|
TWNP
3218
DELISTED
Twin Hospitality Group
TWNP
| $7.12K | ﹤0.01% |
+10,658
| New | +$28.8K |
|
3219
Integrated Media Technology
IMTE
$1.55M
| $7.1K | ﹤0.01% |
+12,183
| New | +$10.5K |
|
|
DCOY
3220
Decoy Therapeutics
DCOY
$2.15M
| $7.1K | ﹤0.01% |
+912
| New | +$23.6K |
|
|
ADN
3221
DELISTED
Advent Technologies
ADN
| $7.07K | ﹤0.01% |
+16,835
| New | +$52.6K |
|
|
ZDAI
3222
DirectBooking Technology Co
ZDAI
$13.7M
| $6.68K | ﹤0.01% |
+2,044
| New | +$13.8K |
|
|
KWM
3223
K Wave Media Ltd
KWM
$9.15M
| $6.63K | ﹤0.01% |
16,164
-48,491
| -75% | -$69.6K |
|
3224
Jin Medical International
ZJYL
$15M
| $6.3K | ﹤0.01% |
1,432
+543
| +61% | +$3.2K |
|
|
EDHL
3225
Everbright Digital
EDHL
$6.95M
| $6.26K | ﹤0.01% |
+1,044
| New | +$13.1K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.